Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 03-Apr-24 8:11 PM View:  | 2seventy Bio, Inc. (TSVT) | 01-Apr-24 | Grant | 56,250 | -- | -- | 22% 252.34K to 308.58K | |
| 09-Jan-24 4:09 PM View: | 2seventy Bio, Inc. (TSVT) | 08-Jan-24 | Grant | 91,000 | -- | -- | 56% 161.34K to 252.34K | |
| 09-Jan-24 4:09 PM View: | 2seventy Bio, Inc. (TSVT) | 05-Jan-24 | Sale | 1,380 | $3.75 | $5,179.97 | (< 1%) 162.72K to 161.34K | |
| 05-Jan-24 4:29 PM View: | 2seventy Bio, Inc. (TSVT) | 03-Jan-24 | Sale | 33,651 | $3.87 | $130,179.00 | (17%) 196.37K to 162.72K | |
| 24-Aug-23 5:04 PM View: | 2seventy Bio, Inc. (TSVT) | 22-Aug-23 | Sale | 7,031 | $5.49 | $38,575.60 | (3%) 203.4K to 196.37K | |
| 07-Aug-23 4:06 PM View: | 2seventy Bio, Inc. (TSVT) | 03-Aug-23 | Sale | 6,906 | $6.13 | $42,304.10 | (3%) 210.3K to 203.4K | |
| 15-Feb-23 5:56 PM View: | 2seventy Bio, Inc. (TSVT) | 13-Feb-23 | Sale | 637 | $12.86 | $8,191.82 | (< 1%) 210.94K to 210.3K | |
| 03-Feb-23 4:59 PM View: | 2seventy Bio, Inc. (TSVT) | 01-Feb-23 | Grant | 132,143 | -- | -- | 168% 78.8K to 210.94K | |
| 18-Jan-23 5:18 PM View: | 2seventy Bio, Inc. (TSVT) | 11-Jan-23 | Sale | 1,077 | $10.63 | $11,446.50 | (1%) 79.87K to 78.8K | |
| 11-Jan-23 4:23 PM View: | 2seventy Bio, Inc. (TSVT) | 09-Jan-23 | Sale | 3,222 | $10.33 | $33,298.40 | (4%) 83.1K to 79.87K | |
| 08-Aug-22 5:08 PM View: | 2seventy Bio, Inc. (TSVT) | 05-Aug-22 | Sale | 4,152 | $16.23 | $67,397.30 | (5%) 87.25K to 83.1K | |
| 19-Jul-22 4:22 PM View: | 2seventy Bio, Inc. (TSVT) | 15-Jul-22 | Sale | 4,080 | $13.81 | $56,344.40 | (4%) 91.33K to 87.25K | |
| 05-May-22 8:36 PM View: | 2seventy Bio, Inc. (TSVT) | 01-Mar-22 | Grant | 33,750 | -- | -- | 59% 57.58K to 91.33K | |
| 22-Feb-22 4:08 PM View: | 2seventy Bio, Inc. (TSVT) | 17-Feb-22 | Sale | 427 | $14.78 | $6,311.06 | (< 1%) 58.01K to 57.58K | |
| 11-Jan-22 5:33 PM View: | 2seventy Bio, Inc. (TSVT) | 07-Jan-22 | Market Sale | 896 | $23.91 | $21,421.40 | (2%) 58.9K to 58.01K | 2% |
| 17-Nov-21 8:55 AM View: | Bluebird Bio, Inc. (BLUE) | 11-Nov-21 | Acquisition (other) | 14,768 | -- | -- | 184% 8.03K to 22.8K | |
| 16-Nov-21 6:34 AM View: | 2seventy Bio, Inc. (TSVT) | 11-Nov-21 | Grant | 56,226 | -- | -- | 2102% 2.67K to 58.9K | |
| 18-Feb-21 5:22 PM View: | Bluebird Bio, Inc. (BLUE) | 17-Feb-21 | Market Sale | 693 | $28.16 | $19,515.80 | (2%) 36.22K to 35.53K | |
| 18-Feb-21 5:22 PM View: | Bluebird Bio, Inc. (BLUE) | 16-Feb-21 | Grant | 14,641 | -- | -- | 68% 21.58K to 36.22K | |
| 17-Feb-21 5:23 PM View: | Bluebird Bio, Inc. (BLUE) | 12-Feb-21 | Market Sale | 1,216 | $45.52 | $55,352.30 | (5%) 22.8K to 21.58K | 38% |
| 08-Jan-21 5:57 PM View: | Bluebird Bio, Inc. (BLUE) | 06-Jan-21 | Market Sale | 949 | $45.05 | $42,755.80 | (4%) 23.75K to 22.8K | (7%) |
| 04-Mar-20 4:19 PM View: | Bluebird Bio, Inc. (BLUE) | 02-Mar-20 | Grant | 10,000 | -- | -- | 73% 13.75K to 23.75K | |
| 18-Feb-20 7:14 PM View: | Bluebird Bio, Inc. (BLUE) | 13-Feb-20 | Market Sale | 1,254 | $90.60 | $113,612.00 | (8%) 15.0K to 13.75K | 50% |
| 05-Mar-19 4:30 PM View: | Bluebird Bio, Inc. (BLUE) | 01-Mar-19 | Grant | 15,000 | -- | -- | 100% 0 to 15.0K | |
| 17-Oct-18 6:28 PM View: | Amicus Therapeutics, Inc. (FOLD) | 15-Oct-18 | Option Exercise | 10,000 | $2.45 | $24,500.00 | 9% 117.62K to 127.62K | |
| 17-Oct-18 6:28 PM View: | Amicus Therapeutics, Inc. (FOLD) | 15-Oct-18 | Market Option Sale (Planned) | 10,000 | $12.23 | $122,275.00 | (8%) 127.62K to 117.62K | (98%) |
| 05-Jul-18 4:27 PM View: | Amicus Therapeutics, Inc. (FOLD) | 02-Jul-18 | Option Exercise | 10,000 | $2.45 | $24,500.00 | 9% 107.62K to 117.62K | |
| 05-Jul-18 4:27 PM View: | Amicus Therapeutics, Inc. (FOLD) | 02-Jul-18 | Market Option Sale (Planned) | 10,000 | $15.63 | $156,292.00 | (9%) 117.62K to 107.62K | (55%) |
| 04-Apr-18 5:38 PM View: | Amicus Therapeutics, Inc. (FOLD) | 02-Apr-18 | Option Exercise | 10,000 | $2.45 | $24,500.00 | 9% 117.62K to 127.62K | |
| 04-Apr-18 5:38 PM View: | Amicus Therapeutics, Inc. (FOLD) | 02-Apr-18 | Market Option Sale (Planned) | 10,000 | $14.26 | $142,648.00 | (8%) 127.62K to 117.62K | (70%) |
| 05-Jan-18 6:21 PM View: | Amicus Therapeutics, Inc. (FOLD) | 03-Jan-18 | Grant | 29,803 | -- | -- | 31% 95.12K to 124.92K | |
| 05-Jan-18 6:21 PM View: | Amicus Therapeutics, Inc. (FOLD) | 03-Jan-18 | Payment of Exercise | 7,302 | $15.67 | $114,422.00 | (6%) 124.92K to 117.62K | (55%) |
| 04-Jan-18 5:11 PM View: | Amicus Therapeutics, Inc. (FOLD) | 02-Jan-18 | Option Exercise | 10,000 | $14.72 | $147,181.00 | 11% 95.12K to 105.12K | 65% |
| 04-Jan-18 5:11 PM View: | Amicus Therapeutics, Inc. (FOLD) | 02-Jan-18 | Market Option Sale (Planned) | 10,000 | $14.72 | $147,181.00 | (10%) 105.12K to 95.12K | (65%) |
| 16-Oct-17 9:33 PM View: | Amicus Therapeutics, Inc. (FOLD) | 12-Oct-17 | Option Exercise | 40,000 | $14.25 | $570,132.00 | 42% 95.12K to 135.12K | 70% |
| 16-Oct-17 9:33 PM View: | Amicus Therapeutics, Inc. (FOLD) | 12-Oct-17 | Market Option Sale (Planned) | 40,000 | $14.25 | $570,132.00 | (30%) 135.12K to 95.12K | (70%) |
| 19-Jun-17 4:06 PM View: | Amicus Therapeutics, Inc. (FOLD) | 15-Jun-17 | Payment of Exercise | 1,554 | $8.79 | $13,659.70 | (2%) 96.92K to 95.37K | (176%) |
| 05-Jan-17 9:21 PM View: | Amicus Therapeutics, Inc. (FOLD) | 03-Jan-17 | Grant | 60,975 | -- | -- | 170% 35.95K to 96.92K | |
| 22-Sep-16 4:09 PM View: | Amicus Therapeutics, Inc. (FOLD) | 20-Sep-16 | Option Exercise | 3,500 | $8.00 | $28,000.00 | 7% 52.95K to 56.45K | 203% |
| 22-Sep-16 4:09 PM View: | Amicus Therapeutics, Inc. (FOLD) | 20-Sep-16 | Market Option Sale (Planned) | 3,500 | $8.00 | $28,012.80 | (6%) 56.45K to 52.95K | (203%) |
| 22-Sep-16 4:09 PM View: | Amicus Therapeutics, Inc. (FOLD) | 20-Sep-16 | Market Sale (Planned) | 17,000 | $8.00 | $136,062.00 | (32%) 52.95K to 35.95K | (203%) |
| 17-Jun-16 12:24 PM View: | Amicus Therapeutics, Inc. (FOLD) | 15-Jun-16 | Grant | 15,000 | -- | -- | 40% 37.95K to 52.95K | |
| 06-Jan-16 4:10 PM View: | Amicus Therapeutics, Inc. (FOLD) | 04-Jan-16 | Payment of Exercise | 18,625 | $9.03 | $168,184.00 | (33%) 56.58K to 37.95K | (169%) |
| 06-Jan-16 4:10 PM View: | Amicus Therapeutics, Inc. (FOLD) | 04-Jan-16 | Option Exercise | 50,000 | -- | -- | 760% 6.58K to 56.58K | |
| 22-Sep-15 4:21 PM View: | Amicus Therapeutics, Inc. (FOLD) | 21-Sep-15 | Option Exercise | 15,236 | $16.78 | $255,634.00 | 27% 56.58K to 71.81K | 45% |
| 22-Sep-15 4:21 PM View: | Amicus Therapeutics, Inc. (FOLD) | 21-Sep-15 | Market Option Sale (Planned) | 15,236 | $16.78 | $255,634.00 | (21%) 71.81K to 56.58K | (45%) |
| 23-Jun-15 8:08 PM View: | Amicus Therapeutics, Inc. (FOLD) | 19-Jun-15 | Option Exercise | 15,235 | $13.26 | $202,057.00 | 27% 56.58K to 71.81K | 83% |
| 23-Jun-15 8:08 PM View: | Amicus Therapeutics, Inc. (FOLD) | 19-Jun-15 | Market Option Sale | 15,235 | $13.26 | $202,057.00 | (21%) 71.81K to 56.58K | (83%) |
| 12-May-15 9:40 PM View: | Amicus Therapeutics, Inc. (FOLD) | 11-May-15 | Market Option Sale (Planned) | 24,800 | $10.84 | $268,810.00 | (79%) 31.38K to 6.58K | (124%) |
| 12-May-15 9:40 PM View: | Amicus Therapeutics, Inc. (FOLD) | 08-May-15 | Payment of Exercise | 18,625 | $10.80 | $201,150.00 | (37%) 50.0K to 31.38K | (125%) |